E_DEPRECATED Error in file �functions_general.php� at line 301: Function utf8_encode() is deprecated Celgene - ProfileE_DEPRECATED Error in file �functions_general.php� at line 348: Function utf8_encode() is deprecated E_DEPRECATED Error in file �functions_general.php� at line 301: Function utf8_encode() is deprecated

PharmiNews

Directory of Pharma Companies and News

Company Profile

E_DEPRECATED Error in file �functions_general.php� at line 301: Function utf8_encode() is deprecated E_DEPRECATED Error in file �functions_general.php� at line 357: Function utf8_encode() is deprecated E_DEPRECATED Error in file �functions_general.php� at line 375: Function utf8_encode() is deprecated E_DEPRECATED Error in file �functions_general.php� at line 400: Function utf8_encode() is deprecated E_DEPRECATED Error in file �functions_general.php� at line 317: Function utf8_encode() is deprecated E_DEPRECATED Error in file �functions_general.php� at line 292: Function utf8_encode() is deprecated E_DEPRECATED Error in file �functions_general.php� at line 284: Function utf8_encode() is deprecated E_DEPRECATED Error in file �functions_general.php� at line 348: Function utf8_encode() is deprecated

Celgene

E_DEPRECATED Error in file �functions_general.php� at line 326: Function utf8_encode() is deprecated

E_DEPRECATED Error in file �functions_general.php� at line 326: Function utf8_encode() is deprecated Celgene logo

E_DEPRECATED Error in file �functions_general.php� at line 186: Function utf8_encode() is deprecated

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation.

Keywords:

E_DEPRECATED Error in file �company-code.php� at line 190: Function utf8_encode() is deprecated E_DEPRECATED Error in file �functions_general.php� at line 301: Function utf8_encode() is deprecated

Celgene News

Date	News
2018-07-10	Anti-PD-L1 Immunotherapy Plus ABRAXANE® Significantly Reduced the Risk of Disease Worsening or Death in Patients with Me...
2018-07-09	Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE' Stud...
2018-07-02	Celgene Corporation to Announce Second Quarter 2018 Results on July 26, 2018
2018-06-28	Celgene and Acceleron Announce Luspatercept Achieved Primary and Key Secondary Endpoints in Phase III ‘MEDALIST' Study i...
2018-06-19	Celgene Corporation Announces Appointment of Jonathan Biller as Executive Vice President and General Counsel Following t...
2018-06-03	Celgene Announces Updated Safety and Efficacy Data from the TRANSCEND Trial of liso-cel (JCAR017) in Patients with Relap...
2018-06-03	Results of Phase III RELEVANCE Study Comparing REVLIMID plus Rituximab (R²) Versus Rituximab Plus Chemotherapy in Patien...
2018-06-01	Results of Phase III OPTIMISMM Study Presented at ASCO 2018 Showed the PVd Triplet Improved PFS in Early Lines of Relaps...
2018-06-01	Updated Results of Ongoing Multicenter Phase I Study of bb2121 anti-BCMA CAR T Cell Therapy Continue to Demonstrate Deep...
2018-05-31	Celgene Corporation Announces Hiring of David V. Elkins as Executive Vice President, Chief Financial Officer and Appoint...